Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schimke

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|November 1, 1996
Event-related desynchronization (ERD) and the Dm effect: does alpha desynchronization during encoding predict later recall performance?W Klimesch, H Schimke, M Doppelmayr, et al.
Neuropsychobiology|January 1, 1995
Clinical case report: opiate antagonist and event-related desynchronization in 2 autistic boysP Lensing, H Schimke, W Klimesch, et al.
Leukemia|August 15, 2017
Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study groupM A Hoechstetter, R Busch, B Eichhorst, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|November 1, 1996
Event-related desynchronization (ERD) and the Dm effect: does alpha desynchronization during encoding predict later recall performance?W Klimesch, H Schimke, M Doppelmayr, et al.
Neuropsychobiology|January 1, 1995
Clinical case report: opiate antagonist and event-related desynchronization in 2 autistic boysP Lensing, H Schimke, W Klimesch, et al.
Leukemia|August 15, 2017
Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study groupM A Hoechstetter, R Busch, B Eichhorst, et al.
Pageof 2